Dr. Vijay Patil

Dr. Vijay Patil performs major interventions in the following specialities:

• Medical Oncology

• Seth GS Medical College and KEM Hospital (MBBS)
• PGIMER, Chandigarh (MD Radiation Oncology )
• Tata Memorial Cancer Center, Mumbai (DM Medical Oncology)

• Patil, Vijay, Vanita Noronha, Sachin Babanrao Dhumal, Amit Joshi, Nandini Menon, Atanu Bhattacharjee, Suyash Kulkarni, et al. 2020. “Low-Cost Oral Metronomic Chemotherapy versus Intravenous Cisplatin in Patients with Recurrent, Metastatic, Inoperable Head and Neck Carcinoma: An Open-Label, Parallel-Group, Non-Inferiority, Randomised, Phase 3 Trial.” The Lancet. Global Health 8 (9): e1213–22.
• Babanrao Dhumal, Sachin, Vijay Patil, Deevyashali Parekh, Vanita Noronha, Nandini Menon, Zoya Peelay, Kavita Prakash Nawale, and Kumar Prabhash. 2023. “Long Term Outcomes of Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early Failure Oral Cancer.” The Lancet Regional Health. Southeast Asia 12 (100143): 100143.
• Patil, Vijay, Vanita Noronha, Sameer Shrirangwar, Nandini Menon, George Abraham, Arun Chandrasekharan, and Kumar Prabhash. 2021. “Aspiration Pneumonia in Head and Neck Cancer Patients Undergoing Concurrent Chemoradiation from India: Findings from a Post Hoc Analysis of a Phase 3 Study.” Cancer Medicine 10 (19): 6725–35.
• Dhumal, Sachin; Patil, Vijay1; Noronha, Vanita1,; Joshi, Amit1; Menon, Nandini1; Nawale, Kavita1; Tambe, Rupali1; Prabhash, Kumar1. Post hoc analysis of the screening log of phase III investigator-initiated randomized clinical trial comparing palliative oral metronomic versus intravenous chemotherapy in head-and-neck cancer. Cancer Research, Statistics, and Treatment 4(4):p 642-646, Oct–Dec 2021.

• Consultant - P D Hinduja National Hospital And Medical Research Centre
• Consultant - Tieten Medicity Super Speciality Hospital, Thane West
• Consultant - Mangal Anand Hospital